17-Apr-2025	Results of Meeting

12-Mar-2025	2025 EGM Letter to Shareholders, Notice of Meeting and Proxy

12-Nov-2024	Nyrada Annual General Meeting Results

5-Nov-2024	2024 AGM Addendum to the Notice of Meeting and Proxy

28-Oct-2024	Proposed issue of securities - NYR

28-Oct-2024	Proposed issue of securities - NYR

28-Oct-2024	Investor Presentation

28-Oct-2024	Nyrada Successfully Raises $3.36 Million via Placement

30-Sep-2024	2024 Annual General Meeting Access Letter, Notice and Proxy

22-Aug-2024	Annual Report for year ended 30 June 2024

27-May-2024	Upcoming Expiry of Unlisted Warrants

16-May-2024	Nyrada General Meeting Results

2-Apr-2024	2024 EGM Letter to Shareholders and Proxy

2-Apr-2024	2024 EGM Notice of Meeting and Proxy

6-Mar-2024	Nyrada Successfully Raises $1.755 Million via Placement

28-Feb-2024	Nyrada CEO James Bonner interview with 180 Markets

19-Jan-2024	Amended and Restated Certificate of Incorporation and Bylaws

8-Dec-2023	Nyrada Receives A$3.54M R&D Tax Incentive Rebate

20-Nov-2023	Nyrada Annual General Meeting Results

1-Nov-2023	2023 AGM Chair Letter to Shareholders

17-Oct-2023	2023 AGM Notice of Meeting and Proxy

17-Oct-2023	2023 AGM Letter to Shareholders and Proxy

28-Aug-2023	Annual Report for year ended 30 June 2023

28-Aug-2023	Appendix 4G and Corporate Governance Statement

20-Jul-2023	Nyrada Review of Operating Costs

26-Apr-2023	Quarterly Activities Report and Appendix 4C

16-Jan-2023	Notification of cessation of securities - NYR

21-Nov-2022	Results of Meeting

21-Nov-2022	AGM Presentation by James Bonnar CEO

21-Nov-2022	Nyrada AGM 2022 Chairmans Address

18-Nov-2022	Nyrada Receives A$1.2M R&D Tax Incentive Rebate

27-Oct-2022	CEO Remuneration Update

18-Oct-2022	2022 AGM Letter to Shareholders and Proxy

18-Oct-2022	2022 AGM Notice of Meeting and Proxy

2-Aug-2022	Nyrada Board Changes

2-Aug-2022	Initial Director's Interest Notice - GM

2-Aug-2022	Final Director's Interest Notice - PM

17-Jan-2022	Application for quotation of securities - NYR

17-Jan-2022	Change of Director's Interest Notice - ID

17-Jan-2022	Change of Director's Interest Notice - MF

17-Jan-2022	Change of Director's Interest Notice - RW

17-Jan-2022	Change of Director's Interest Notice - JM

17-Jan-2022	Change of Director's Interest Notice - CC

17-Jan-2022	Change of Director's Interest Notice - PM

12-Jan-2022	Nyrada Receives A$1.3M R&D Tax Incentive Rebate

10-Dec-2021	Release of Securities from Escrow

19-Nov-2021	Nyrada Annual General Meeting Results

19-Nov-2021	Annual General Meeting Presentation

19-Nov-2021	Nyrada AGM 2021 Chairman's Address

19-Oct-2021	2021 AGM Letter to Shareholders and Proxy

3-Sep-2021	Updated Share Trading Policy

30-Jun-2021	Change of Director's Interest Notice - CC

30-Jun-2021	Change of Director's Interest Notice - ID

30-Jun-2021	Change of Director's Interest Notice - RW

30-Jun-2021	Change of Director's Interest Notice - MF

30-Jun-2021	Change of Director's Interest Notice - PM

30-Jun-2021	Change of Director's Interest Notice - JM

30-Jun-2021	Change in substantial holding

30-Jun-2021	Change in substantial holding

29-Jun-2021	Cleansing Statement

29-Jun-2021	Confirmation of Capital Structure, CDIs on Issue

29-Jun-2021	Notification regarding unquoted securities - NYR

29-Jun-2021	Application for quotation of securities - NYR

29-Jun-2021	Application for quotation of securities - NYR

16-Jun-2021	Results of Meeting

11-May-2021	Notice of Extraordinary General Meeting/Proxy Form

6-May-2021	Nyrada Receives A$1.0M R&D Tax Incentive Rebate

26-Apr-2021	Change of Registered Office and Principal Place of Business

30-Mar-2021	Change in substantial holding

30-Mar-2021	Ceasing to be a substantial holder

30-Mar-2021	Change in substantial holding

30-Mar-2021	Cleansing Statement

30-Mar-2021	Appendix 2A

25-Mar-2021	Change in substantial holding

22-Mar-2021	Proposed issue of Securities - NYR

22-Mar-2021	Nyrada Receives Firm Commitments to Raise A$11 Million

17-Mar-2021	Trading Halt

5-Mar-2021	Change of Director's Interest Notice - JM

2-Mar-2021	Nyrada Newsletter February 2021

24-Feb-2021	Appendix 3G

24-Feb-2021	Change of Director's Interest Notice - MF

16-Feb-2021	Lapsing of balance of Unlisted SAB Options

16-Feb-2021	Cleansing Statement

16-Feb-2021	Appendix 2A

29-Jan-2021	Trading Halt

22-Jan-2021	Unlisted Scientific Advisory Board Options Expiry 15 Feb 21

18-Jan-2021	Change of Director's Interest Notice - ID

18-Jan-2021	Appendix 3G

18-Jan-2021	Appendix 3G

18-Jan-2021	Appendix 3G

7-Jan-2021	Release of Securities from Escrow

6-Jan-2021	Change in substantial holding

14-Dec-2020	Appointment of New Auditor

8-Dec-2020	Change in substantial holding

2-Dec-2020	Cleansing Statement

2-Dec-2020	Appendix 2A

26-Nov-2020	Change of Director's Interest Notice - JM

25-Nov-2020	Change of Director's Interest Notice - MF

25-Nov-2020	Appendix 2A

19-Nov-2020	Nyrada Annual General Meeting Results

19-Nov-2020	Presentation to 2020 Annual General Meeting of Shareholders

19-Nov-2020	Nyrada AGM 2020 Chairmans Address

16-Nov-2020	Release of Securities from Escrow

9-Nov-2020	Unlisted Convertible Note Options Expiring 30 November 2020

3-Nov-2020	2020 Annual General Meeting Reminder

19-Oct-2020	Letter to Shareholders and Proxy Form in relation to AGM

19-Oct-2020	Notice of Annual General Meeting and Proxy Form

24-Sep-2020	Nyrada Newsletter September 2020

17-Sep-2020	Notification of Date of 2020 Annual General Meeting

11-Sep-2020	Change of Director's Interest Notice - JM

9-Sep-2020	Nyrada Investor Webinar

8-Sep-2020	Initial Director's Interest Notice - ID

8-Sep-2020	Final Director's Interest Notice - GK

8-Sep-2020	Annual Report to 30 June 2020

8-Sep-2020	Appendix 4G and Corporate Governance Statement

31-Aug-2020	Nyrada Board Changes

8-Jul-2020	Change in substantial holding

25-Jun-2020	Nyrada Newsletter June 2020

27-Apr-2020	Change of Director's Interest Notice - JM

22-Apr-2020	Appointment of New Chief Financial Officer

20-Apr-2020	Preclinical Program & Corporate Update Global Webinar

6-Apr-2020	Nyrada Newsletter Released

16-Mar-2020	Update on Progress in Nyrada Programs

20-Jan-2020	Nyrada Inc - Chairman's letter to shareholders

20-Jan-2020	Becoming a substantial holder

16-Jan-2020	NOX: Listing of Nyrada Inc. spin-off on ASX

16-Jan-2020	NYR Commences Trading on the ASX

16-Jan-2020	Becoming a substantial holder

16-Jan-2020	Becoming a substantial holder

16-Jan-2020	Initial Director's Interest Notice

16-Jan-2020	Initial Director's Interest Notice

16-Jan-2020	Initial Director's Interest Notice

16-Jan-2020	Initial Director's Interest Notice

16-Jan-2020	Initial Director's Interest Notice

16-Jan-2020	Initial Director's Interest Notice

15-Jan-2020	Regulation S-Foreign Ownership Restrictions

14-Jan-2020	Confirmation and Waiver under ASX Listing Rules

14-Jan-2020	Pre-Quotation Disclosure

14-Jan-2020	Updated Pro-forma - Financial Position and Commitments

14-Jan-2020	Securities Trading Policy

14-Jan-2020	Capital Structure and Restricted Securities

14-Jan-2020	Financial Statements Year End 30 June 2019

14-Jan-2020	Financial Statements Year End 30 June 2018

14-Jan-2020	Corporate Governance Statement

14-Jan-2020	Equity Incentive Plan

14-Jan-2020	Amended and Restated Certificate of Incorporation and Bylaws

14-Jan-2020	Supplementary Prospectus

14-Jan-2020	Prospectus

14-Jan-2020	Appendix 1A, Information Form and Checklist, Annexure 3

14-Jan-2020	Distribution Schedule

14-Jan-2020	Top 20 Securityholders

14-Jan-2020	ASX Market Release - Admission and Quotation